HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

John Santiago Selected Research

CB002

1/2021A subset of CB002 xanthine analogs bypass p53-signaling to restore a p53 transcriptome and target an S-phase cell cycle checkpoint in tumors with mutated-p53.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


John Santiago Research Topics

Disease

1Neoplasm Metastasis (Metastasis)
01/2021
1Neoplasms (Cancer)
01/2021

Drug/Important Bio-Agent (IBA)

1CB002IBA
01/2021
1Caffeine (No Doz)FDA LinkGeneric
01/2021
1Pentoxifylline (Trental)FDA LinkGeneric
01/2021
1Theophylline (Theon)FDA LinkGeneric
01/2021
1XanthinesIBA
01/2021
1XanthineIBA
01/2021

Therapy/Procedure

1Therapeutics
01/2021